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Background: PHD-histone interactions are essential in epigenetic signaling.
Results: Calixarenes can disrupt PHD-H3K4me complexes in vitro and in vivo.
Conclusion: The inhibitory activity of calixarenes depends on the binding affinities of PHD fingers for H3K4me and the
methylation state of histone.
Significance: This approach provides new tools for probing histone binding activities of methyllysine readers.
Plant homeodomain (PHD) finger-containing proteins are
implicated in fundamental biological processes, including tran-
scriptional activation and repression, DNA damage repair, cell
differentiation, and survival. The PHD finger functions as an
epigenetic reader that binds to posttranslationally modified or
unmodified histone H3 tails, recruiting catalytic writers and
erasers and other components of the epigenetic machinery to
chromatin. Despite the critical role of the histone-PHD interac-
tion in normal and pathological processes, selective inhibitors of
this association have not been well developed. Here we demon-
strate that macrocyclic calixarenes can disrupt binding of PHD
fingers to methylated lysine 4 of histone H3 in vitro and in vivo.
The inhibitory activity relies on differences in binding affinities
of the PHD fingers for H3K4me and the methylation state of the
histone ligand, whereas the composition of the aromatic
H3K4me-binding site of the PHD fingers appears to have no
effect. Our approach provides a novel tool for studying the bio-
logical roles of methyllysine readers in epigenetic signaling.
The plant homeodomain (PHD)4 finger is found in a wide
range of proteins that mediate epigenetic signaling (reviewed in
Ref. 1). This evolutionarily conserved cysteine-rich module is
present in a single copy or multiple copies in 291 Homo sapiens,
17 Saccharomyces cerevisiae, 58 Drosophila melanogaster, and
45 Caenorhabditis elegans proteins (SMART). The PHD fingers
comprise one of the largest families of epigenetic effectors and,
ultimately, histone readers. They bind to posttranslationally
modified and unmodified histone H3 tails, recruiting and sta-
bilizing their host proteins at chromatin. The most common
function of this domain, exemplified by the PHD fingers of
BPTF and ING2, is recognition of trimethylated lysine 4 of his-
tone H3 (H3K4me3) (2–5). Another subset of the PHD fingers
has been shown to bind to the unmodified histone H3 tail (6, 7),
and a smaller number of PHD fingers are capable of associating
with other posttranslational modifications (PTMs) (8).
PHD fingers that recognize histone H3K4me3 do so with
high specificity and affinity. This interaction tethers various
transcription factors and chromatin-modifying complexes to
H3K4me3-enriched genomic regions and is required for funda-
mental biological processes, including transcriptional regula-
tion, chromatin remodeling, nucleosome dynamics, cell cycle
control, and DNA damage responses. Moreover, colocalization
and stabilization of nuclear enzymes and subunits of enzymatic
complexes at chromatin often depend on PHD finger activity.
These enzymes, also known as writers and erasers, maintain the
physiological PTM balance in a spatiotemporal manner that is
crucial for cell homeostasis. Loss of such balance results in
abnormal gene expression, which can lead to the inactivation of
genes required during normal processes, for example tumor
suppressor genes, and overexpression of naturally silenced
genes, including oncogenes, therefore driving or contributing
to the development of disease.
Aberrant chromatin-binding activities of PHD finger-con-
taining proteins due to mutations, deletions, and translocations
have been linked directly to cancer, immunodeficiency, and
neurological disorders (reviewed in Refs. 9, 10). Deregulation of
PHD-dependent H3K4me3 binding of the demethylase
JARID1A, as a consequence of a gene fusion to the common
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translocation partner NUP98, triggers hematopoietic malig-
nancies (11). Binding of the PHD fingers to H3K4me3 is essen-
tial for tumor-suppressive, or, in some instances, oncogenic
mechanisms of the inhibitor of growth 1–5 (ING1–5) proteins
(reviewed in Ref. 12). Loss of the third PHD (PHD3) finger of
the methyltransferase MLL1 in the MLL-ENL translocation
causes constitutive transactivation of the fused protein, which
promotes leukemogenesis (13). Mutations in the PHD finger of
RAG2 have been found in patients with severe combined
immunodeficiency syndrome and in Omenn syndrome, in
which V(D)J recombination and the formation of T and B cell
receptors are impaired (14). Owing to their prominent role in
epigenetic regulation, the PHD finger-containing proteins
could be valuable diagnostic markers or pharmacological tar-
gets in preventing or treating these diseases.
Recent breakthroughs in biological and medical applications
of small molecule antagonists for acetyllysine-binding bro-
modomain, methyllysine-binding MBT and chromodomain,
and arginine-recognizing WD40 demonstrate the vast poten-
tial of targeting the histone readers (15–20). A number of epi-
genetic inhibitors are in clinical trials as anticancer and anti-
inflammatory agents (15, 21, 22). Many more show beneficial
effects in animal and cellular models and are used successfully
in testing the biological activities of reader-, writer- and eraser-
containing proteins. To date, various small molecule inhibitors
and peptidomimetics have been designed to block the interac-
tion of a histone reader by competing with a histone substrate
for the same narrow, deep, and therefore druggable binding
site. However, the histone H3K4me3 tail is bound in a wide and
shallow binding site of the PHD finger. This binding site is not
easily amenable to the design of conventional small molecule
inhibitors, and only a few groups have reported progress in this
regard (23, 24).
Alternatively, PTM-reader complexes could be disrupted
using chemicals that target PTMs rather than readers. Supra-
molecular caging compounds, including synthetic receptors,
chelating macrocycles, and calixarenes, have been shown to
coordinate unmodified and posttranslationally modified amino
acids and, therefore, can be applied for studying epigenetic
mechanisms (25–31, 45, 46). We have demonstrated previously
that calixarenes inhibit binding of the second PHD finger of
CHD4 to histone H3 trimethylated at Lys-9, although this bind-
ing does not involve the formation of a methyllysine-recogniz-
ing aromatic cage (32, 33). Here we characterize the mecha-
nisms by which calixarenes interact with the canonical PHD-
H3K4me3 complexes and examine the effect of the aromatic
cage architecture on these interactions. Our results reveal
that calixarenes display selectivity in disrupting the associa-
tion of PHD fingers with the methylated histone H3K4 tail.
We show that the calixarene activity relies on differences in
binding affinities of the PHD fingers for H3K4me and the
methylation state of the histone substrate and that the caging
compound can be modified further to enhance its inhibitory
capability toward individual PHD fingers. This approach
provides new tools for probing biological functions of the
methyllysine readers.
Experimental Procedures
Synthesis of Calix[4]arene Derivatives—Calixarene (1) was
purchased from TCI America. Calixarenes (2– 8) were synthe-
sized as described in Refs. 26, 32 and the supplemental Experi-
mental Procedures.
Fluorescence Displacement Assay—The FDA was performed
as described in the supplemental Experimental Procedures.
Protein Purification—The constructs containing the ING2
PHD (212–264), MLL5 PHD (117–181), MLL1 PHD3 (1565–
1627), and JARID1A PHD3 (1608 –1659) were expressed in
Escherichia coli Rosetta2 BL21(DE3) pLysS cells in Luria broth
or [15N]H4Cl-supplemented minimal media. Protein produc-
tion was induced with 0.5 mM isopropyl 1-thio--D-galactopy-
ranoside at 18 °C overnight. Bacterial cells were harvested by
centrifugation and lysed by sonication. The 15N-labeled GST
fusion proteins were purified by GST affinity chromatography
on glutathione-Sepharose 4B beads (GE Healthcare). The GST
tag was cleaved with Prescission or Thrombin (GE Healthcare)
proteases. The cleaved proteins were eluted and concentrated
in a buffer containing 20 mM Tris-HCl (pH 6.9), 150 mM NaCl,
and 5 mM dithiothreitol.
NMR Spectroscopy—NMR experiments were performed on
500- and 600-MHz Varian INOVA spectrometers at 298 K.
1H,15N heteronuclear single-quantum coherence (HSQC)
spectra were recorded for each 15N-labeled PHD finger (0.1
mM) in the absence and presence of saturating concentrations
of H3K4me2 (1–12) or H3K4me3 (1–12) peptides (synthesized
by the UCD Biophysics Core Facility). Subsequently, increasing
amounts of calixarenes were added in a stepwise manner. Kd
values were calculated by a nonlinear least squares analysis in
Kaleidagraph using the following equation:   max((([L] 
[P]  Kd)  sqrt(sqr([L]  [P]  Kd)  (4  [P]  [L]))) / (2 
[P])), where [L] is the concentration of the peptide, [P] is con-
centration of the protein,  is the observed chemical shift
change, and max is the normalized chemical shift change at
saturation. The normalized chemical shift change was calcu-
lated using the equation [(H)2  (N / 5)2]0.5, where  is
chemical shift in parts per million (ppm).
Pulldown Assays—GST fusion MLL5 PHD and ING2 PHD
proteins (50 M) were incubated with 5 M C-terminal biotiny-
lated peptides (AnaSpec) corresponding to the H3K4me3 (res-
idues 1–21) and H3K4me2 (residues 1–21) histone tails in the
presence or absence of 100 M of calixarenes in 50 l of binding
buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, and
0.2% Triton X-100 at room temperature for 2 h. Streptavidin-
agarose resin (Thermo Scientific) was added to the reaction
mixture and incubated for an additional 2 h. The beads were
collected via centrifugation and washed with binding buffer.
The bound protein was detected by Coomassie staining of an
SDS-PAGE gel.
Fluorescence Polarization Assays—Peptides for fluorescence
polarization (histone H3, residues 1–20) were synthesized as
described previously (34) with the addition of 5-carboxyfluo-
rescein at the C terminus. Binding assays were performed as
described previously (35) with the following modifications.
Reactions were performed in 25 l in black flat bottom 384-well
plates (Costar). Protein was titrated with 20 nM peptide in
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buffer containing 25 mM HEPES (pH 7.5), 100 mM NaCl, and
0.05% Nonidet P-40. Following a 10-min equilibration period at
25 °C, the plates were read on a PHERAstar microplate reader
(BMG Labtech) using a 480-nm excitation filter and 520/
530-nm emission filters. For displacement assays, the indicated
concentrations of (1) were incubated with MLL5 PHD (10 M)
or ING2 PHD (5 M) and 20 nM tracer peptide in the buffer
described above. Anisotropy units were normalized to the sig-
nal in the absence of (1) (100% bound). IC50 values were deter-
mined by variable slope non-linear regression analysis and a
least squares fit using GraphPad Prism v5.
Cell Line and Culture—C2C12 cells were grown in DMEM
supplemented with 10% FBS and penicillin/streptomycin (100
units/ml). To create the MLL5-expressing cell line, C2C12 cells
were transfected with a Tol2 transposon containing full-length
murine MLL5 with an N-terminal FLAG tag under the control of a
Tet-responsive element and a puromycin resistance marker and
the rtTA2S-M2 Tet activator under the control of a PGK pro-
moter (the sequence file can be found in the in supplemental
ExperimentalProcedures) along with the Tol2 transposase.
Integrants were selected and maintained on 2 g/ml puromycin.
Proximity Ligation Assay—10,000 C2C12:FLAG-MLL5 cells
were seeded into each well of an 8-well Lab-Tek chamber slide
with or without 1 g/ml doxycycline and grown at 37 °C, 5% CO2.
After 16 h, (1) or vehicle control was added to the appropriate
wells, and cells were incubated for a further 8 h. The final concen-
tration of (1) was 100 M diluted from a 25 mM stock in 50%
DMSO. Cells were fixed with 4% formaldehyde, permeabilized
with 0.5% saponin and 1% Triton X-100 in PBS, and processed
with the DuoLink proximity ligation assay kit (Sigma-Aldrich, cat-
alog no. DUO92101) according to the instructions of the manu-
facturer. FLAG-MLL5 was labeled with a mouse monoclonal anti-
FLAG antibody (Sigma-Aldrich, catalog no. F1804), and histone
H3K4me3 was labeled with a rabbit polyclonal antibody (Active
Motif, catalog no. 39159) diluted 1:2000 and 1:500, respectively, in
the diluent provided with the kit. Cells were imaged using a Delta
Vision Elite fluorescence microscope with a 60 objective, and
images were analyzed by manually counting fluorescent spots in
three dimensions using the Imaris software suite. 88–104 cells
were quantitated for each condition.
Protein Extracts and Western Blot Analysis—Transfected
cells were washed with PBS once, resuspended in Nonidet
P-40/sucrose buffer (0.32 M sucrose, 3 mM CaCl2, 2 mM MgCl2,
0.1 mM EDTA, and 0.5% Nonidet P-40) and incubated on ice for
5 min. Nuclei were pelleted at 1500  g and washed once with
sucrose buffer without Nonidet P-40. For Western blots, the
nuclei were resuspended in radioimmune precipitation assay
buffer, sonicated (avoiding overheating), and incubated on ice for
10 min. The samples were spun at 14,000  g for 15 min at 4 °C,
and the supernatants were recovered. 50 g of extract was resolved
in 4–20% acrylamide gel and transferred to PVDF by standard
methods. Membranes were blotted with mouse anti-FLAG
(1:5000, Sigma-Aldrich, catalog no. F1804) and rabbit anti-
PARP-1 (1:2000, Santa Cruz Biotechnology, catalog no. sc-1750).
Immunofluorescence—10,000 C2C12:FLAG-MLL5 cells
were seeded into each well of an 8-well Lab-Tek chamber slide
with or without 1 g/ml doxycycline and grown at 37 °C, 5%
CO2 for 24 h. For calixarene-treated cells, vehicle or 100 M (1)
diluted from a 25 mM stock in 50% DMSO was added for the
final 8 h. Cells were fixed with 4% formaldehyde and permeabi-
lized with 0.5% saponin, 1% Triton X-100 in PBS. FLAG-MLL5
was labeled with a mouse monoclonal anti-FLAG antibody
(Sigma-Aldrich, catalog no. F1804) diluted 1:2000 and with an
anti-mouse Cy3 secondary antibody (Jackson ImmunoRe-
search Laboratories, catalog no. 715-165-150) diluted 1:250.
H3K4me3 was labeled with rabbit polyclonal antibody (Active
Motif, catalog no. 39159) diluted 1:500 and with an anti-rabbit
Cy3 secondary antibody (Jackson ImmunoResearch Laborato-
ries, catalog no. 711-165-152) diluted 1:250. Slides were
FIGURE 1. Calix[4]arenes mimic the aromatic cage of PHD fingers. a, sche-
matic showing the disruption of the association of a PHD finger (orange) with
the histone H3K4me3 tail by calixarene (yellow). b, distances between the
aromatic groups in the methyllysine-binding cage of the BPTF PHD finger (left
panel) and distances between sulfur and carbon atoms in calixarene (right
panel) are indicated by dashed lines. c, the calixarene hosts used in this study.
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mounted with the media included with the Duolink PLA kit and
imaged using a Delta Vision Elite fluorescence microscope with
identical exposure settings for each condition.
Results and Discussion
Design of Calixarene Derivatives—PHD fingers recognize
histone H3K4me3 by enclosing trimethyllysine in a cage-like
binding pocket that consists of at least one and up to four aro-
matic residues. Generally, the side chains of these aromatic res-
idues protrude almost perpendicularly to the protein surface
and to each other and are involved in cation- interactions with
the trimethylammonium group of Lys-4 (Fig. 1, a and b). In
search for approaches to inhibit binding of the PHD fingers to
H3K4me3, we designed a set of water-soluble calix[4]arenes
(Fig. 1c). The four linked phenol repeats of calix[4]arenes form
a rigid bucket-shape scaffold, enabling these compounds to trap
methylated lysine in the internal cavity. Because the internal
volume and the diameter of the upper rim of calix[4]arenes
match the internal volume and distances between the aro-
matic groups in the aromatic cage of the PHD finger, we
rationalized that these calixarenes can mimic the natural
K4me3-binding site of the protein (Fig. 1b). The set of calix-
arenes included analogs of p-sulfonatocalixarene (1) carry-
ing amide- or sulfonamide-linked substituents at one or two
positions of its upper rim (2– 8) (Fig. 1c) (26, 32). The bulkiness
and electrostatic properties of the substituents varied to deter-
mine how change in polarity, size, and charge affects the ability
of calixarenes to disrupt the PHD-H3K4me3 complexes.
Selectivities of Calixarenes for Methylated Histone H3—To
examine the effect of substituents on the methyllysine-binding
activity of (1), we characterized the association of calixarenes
(1–7) with histone H3K4me3 peptide (residues 1–12 of H3)
using an FDA (Fig. 2a). In this assay, the histone peptide was
titrated into a calixarene sample containing a Lucigenin dye.
Displacement of the dye by H3K4me3 was monitored through
the change in fluorescence intensity at 485 nm. The equilibrium
dissociation constant (Kd) for the complex of calixarene (1)
with H3K4me3 peptide was found to be 15 nM (Fig. 2b). Substi-
tution of one of the sulfonate groups in (1) with a bulkier, neg-
atively charged or neutral moiety had no effect on this interac-
tion. However, p-bromo-phenyl substituents in (3) and (6)
significantly reduced histone binding, which was further weak-
FIGURE 2. Calixarenes display a selectivity for methylated histone peptides. a, representative FDA binding curves for the indicated peptides and calix-
arenes. b, dissociation constants measured by FDA. Selectivity for H3K4me3 determined by the ratio of H3K4me3 versus H3K9me3. Data are mean  S.D. c,
modeling of the complexes of (1) with H3K4me3 and H3K9me3 peptides. The electrostatic surface potential of the peptides was generated in PyMOL.
Supramolecular Hosts for Histone H3K4me3
22922 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290 • NUMBER 38 • SEPTEMBER 18, 2015
ened in the case of (7), a calixarene carrying two p-carboxy-
phenylsulfonamide groups.
The amino terminus of native histone H3 can also be tri-
methylated at Lys-9. Interestingly, the H3K4me3 and
H3K9me3 PTMs are associated with opposite biological out-
comes. Whereas the former is found at promoters of actively
transcribed genes, the latter is a mark of transcriptionally inac-
tive pericentric heterochromatin. To determine whether calix-
arenes select for specific sequences adjacent to trimethyllysine,
we tested the binding of (1–7) to histone H3K9me3 peptide
(residues 1–12 of H3) by FDA (Fig. 2). We found that the added
substituents in general decrease binding of (1) to H3K9me3,
and bromophenyl-substituted calixarenes (3) and (6) associate
even weaker. A comparison of the binding affinities of calix-
arenes toward H3K4me3 and H3K9me3 reveals that some
calixarenes display a preference for H3K4me3, whereas others
select for H3K9me3. Particularly (1), (4), and (5) showed 8-,
12-, and 10-fold selectivity toward H3K4me3 over
H3K9me3, respectively, whereas (3) and (7) slightly preferred
H3K9me3. These data suggest energetically favorable contacts
of (1), (4), and (5) with the peptide residues surrounding
K4me3. Modeling of the H3K4me3-(1) complex positioned the
negatively charged sulfonate groups of (1) in close proximity to
the positively charged side chains of the Arg-2 and Arg-8 of the
FIGURE 3. Calixarene (1) inhibits binding of the ING2 PHD finger to H3K4me3. a, molecular model depicting disassociation of the ING2 PHD-H3K4me3 complex
because of (1). The crystal structure of the H3K4me3-bound ING2 PHD finger (PDB code 2G6Q) is shown as a ribbon diagram with the H3K4me3 peptide colored green.
The ING2 residues comprising the methyllysine-binding aromatic cage are colored pink, whereas residues involved in a nonspecific interaction with (1) are shown in
blue. b, superimposed 1H,15N HSQC spectra of ING2 PHD, collected as first H3K4me3 peptide and then (1), (4), or (8) were titrated in. The spectra are color-coded
according to the protein:peptide:calixarene molar ratio as shown in the right panel. c, the normalized chemical shift changes observed in the ING2 PHD finger upon
binding to H3K4me3 (red) and inhibition by (1) (blue) as a function of residue. *, peaks disappear; **, peaks move in a different direction. d, superimposed 1H,15N HSQC
spectra of ING2 PHD collected as (1) was titrated in. e, the normalized chemical shift changes observed in the ING2 PHD finger upon interaction with (1) as a function
of residue. f, the residues of the ING2 PHD finger, most perturbed because of the interaction with (1), are mapped onto the structure of the protein.
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peptide. Such additional electrostatic interactions are not possible
in the H3K9me3-(1) complex, where the negatively charged upper
rim of (1) packs against the polar and hydrophobic Ser-10, Thr-11,
and Ala-7 residues of the peptide. Together, FDA experiments
demonstrate that (1), (4), and (5) preferentially bind
H3K4me3 and can be used to modulate the histone-binding
activities of H3K4me3-specific readers, including PHD fingers.
Inhibition of the ING2 PHD-H3K4me3 interaction—The abil-
ity of calixarenes to disrupt PHD finger binding to histone
H3K4me3 was examined by NMR spectroscopy (Fig. 3). We
collected 1H,15N HSQC spectra of the uniformly 15N-labeled
PHD finger of ING2 while H3K4me3 peptide was added grad-
ually to the NMR sample. As anticipated, the histone peptide
induced large chemical shift perturbations (CSPs) in the pro-
tein, confirming direct interaction with H3K4me3 (Fig. 3b, first
panel, red gradient colors). Progressive shifting and broadening
of cross-peaks revealed an intermediate exchange regime on
the NMR time scale, which was consistent with the binding
affinity of the ING2 PHD finger measured for H3K4me3 (Kd,
1.5 M) (3). Subsequent titration of (1) caused the amide reso-
nances of the ING2 PHD finger to shift back to their positions in
the ligand-free form of the protein (blue gradient colors, Fig.
3b), indicating dissociation of the PHD-H3K4me3 complex and
formation of a supramolecular H3K4me3-(1) complex. Con-
trary to (1), we found that the carboxyphenylsulfonamide ana-
log (4) does not disrupt the PHD-H3K4me3 complex despite
the fact that both calixarenes interact with the H3K4me3 pep-
tide almost equally well (Fig. 3b, second panel). The less bulkier
phenyl analog (8) showed a weak inhibition at a PHD:
H3K4me3:(8) ratio of 1:5:5 (Fig. 3b, third panel). These results
suggest that steric hindrance reduces the inhibitory activity of
calixarenes carrying large substituents toward the ING2 PHD
finger complex.
The majority of CSPs in the ING2 PHD finger triggered by
H3K4me3 were reversed complementarily by (1), however,
cross-peaks of Lys-251 and Trp-254 of the protein shifted to a
different position (Fig. 3c and supplemental Fig. S1). To test
whether these residues are involved in a nonspecific interaction
with (1), we titrated (1) into the ING2 PHD finger in the absence
of H3K4me3 (Fig. 3, d–f). Substantial CSPs observed for Lys-
251 and Trp-254 confirmed that these residues are likely
involved in an off-target interaction with (1). The calculated Kd
value of 730 M for this nonspecific interaction was 104-
fold higher than the Kd value for the specific coordination of
H3K4me3 and was in line with affinities measured previously
for weak nonspecific associations between calixarenes and pro-
teins (25).
Inhibition of the ING2 PHD-H3K4me3 interaction by (1)
was corroborated by pulldown assays. We incubated GST-
ING2 PHD with biotinylated histone H3K4me3 peptide (resi-
FIGURE 4. Calixarene (1) impairs the interaction of the ING2 PHD finger with H3K4me3 but does not disturb the interaction with H3K4me2. a, binding
of the GST-fusion ING2 PHD finger to the indicated biotinylated histone peptides in the absence or presence of the indicated calixarenes was examined by
pulldown assay. b, quantitation of the interaction of ING2 PHD with H3 (black) or H3K4me3 (blue) peptides by fluorescence polarization (top panel) or
fluorescence polarization displacement (center panel) by (1). Bottom panel, quantitation of the interaction of (1) with H3 (black) or H3K4me3 (blue) peptides by
fluorescence polarization (bottom). c, overlays of 1H,15N HSQC spectra of the H3K4me2-bound ING2 PHD finger recorded during gradual addition of (1) or (4).
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dues 1–20) and with streptavidin-Sepharose beads in the
absence and presence of calixarenes. After collecting the bead
fraction through centrifugation, the histone-bound PHD finger
was detected by Western blot analysis (Fig. 4a). In the absence
of (1), the ING2 PHD finger bound to H3K4me3, however,
treatment with (1) abrogated this interaction. In support of the
NMR titration experiments, (8) only slightly diminished the
association of the PHD finger with H3K4me3. Therefore,
among all calixarenes tested, (1) appears to be the most effective
inhibitor of the ING2 PHD-H3K4me3 interaction. Fluores-
cence polarization displacement assays revealed a dose-depen-
dent inhibition of the ING2 PHD-H3K4me3 complex by (1),
with an IC50 of 108 M (Fig. 4b).
Calixarenes Do Not Affect the ING2 PHD-H3K4me2
Complex—Both trimethylated species and dimethylated spe-
cies, H3K4me3 and H3K4me2, have been found in overlapping
genomic regions near the gene transcription start sites, how-
ever, these PTMs regulate chromatin in a different way. The
ING2 PHD finger binds to H3K4me2 with an appreciable for an
epigenetic reader affinity (Kd, 15 M) even though it is 10-fold
weaker as compared to the affinity of this protein for H3K4me3
(Kd, 1.5 M) (3). We analyzed the ability of calixarenes to block
binding of the ING2 PHD finger to H3K4me2 using 1H,15N HSQC
titration experiments (Fig. 4c). In contrast to robust inhibition of
the stronger interaction of the ING2 PHD finger with H3K4me3,
we found that (1) does not inhibit the weaker interaction of the
ING2 PHD finger with H3K4me2 at the same protein:peptide:ca-
lixarene ratio of 1:5:5. Calixarene (4) was also unable to disrupt the
PHD-H3K4me2 complex. In agreement, the GST-ING2 PHD fin-
ger recognized immobilized biotinylated H3K4me2 peptide either
in the presence or absence of (1), confirming that (1) does not
eliminate binding of the PHD finger to H3K4me2 (Fig. 4a). This, at
first glance counterintuitive, finding can be explained in terms of
the host-guest capabilities of calixarenes. Calixarene (1) has been
shown to select for a trimethylated lysine residue over an unmod-
ified lysine residue by 70-fold (26), therefore, this high selectivity
most likely accounts for its inability to disrupt the ING2 PHD-
H3K4me2 complex.
Together, the NMR and pulldown data reveal that (1) inhibits
binding of the ING2 PHD finger to H3K4me3 without affecting
its binding to another physiologically relevant ligand,
H3K4me2. The strong selectivity of (1) offers a unique
FIGURE 5. Effects of binding affinity and the aromatic cage topology. a, alignment of PHD finger sequences. Conserved residues are colored pink. The
aromatic cage residues of each PHD finger are indicated by purple ovals. b, a close view of the aromatic cages of the PHD fingers of ING2 (PDB code 2G6Q),
JARID1A (PDB code 3GL6), MLL1 (PDB code 3LQJ), and MLL5 (PDB code 2LV9) (3, 11, 36, 37). The aromatic cage residues of ING2, JARID1A, MLL1, and MLL5 are
labeled and colored pink, yellow, blue, and green, respectively. c, an overlay of the K4me3-binding pockets of ING2, JARID1A, MLL1, and MLL5. d, summary of the
Kd values and aromatic cage topologies of the PHD fingers.
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approach to separate the two functions of the PHD finger,
which would be impossible to achieve using a conventional
small molecule inhibitor of the protein.
Effects of Affinity and the Aromatic Cage Topology—The
topology of the aromatic cage and histone binding affinities
vary significantly among PHD fingers. In attempt to develop
calixarene-based derivatives selective for a particular group of
readers, we compared the PHD fingers of JARID1A, ING2,
MLL1, and MLL5. The aromatic cages of MLL5, JARID1A,
ING2, and MLL1 contain one, two, two, and three aromatic
residues, respectively (Fig. 5). Furthermore, the four PHD fin-
gers have dissimilar methyllysine pocket geometries. The tri-
methylated lysine in the MLL5-H3K4me3 complex occupies
a channel whose walls are made of Trp-141 and Asp-128,
whereas Met-132 resides at the bottom (Fig. 5b) (36).
JARID1A is characterized by a shallow V-shaped groove con-
sisting of two tryptophan residues, Trp-1625 and Trp-1635
(11). By contrast, the two aromatic residues of ING2, Tyr-
215 and Trp-238, are positioned upright and together with
the side chain of Ser-222 form three walls of the cage, with
Met-226 lining the bottom (3). The aromatic cage of MLL1 is
unique because it undergoes a large conformational change
upon binding of H3K4me3. A loop containing Tyr-1581
swings toward the aromatic cage composed of Tyr-1576,
Trp-1594, and Met-1585. The aromatic ring of Tyr-1581
then acts as a lid, closing the cage and burying the trimeth-
yllysine ligand (37).
To determine whether (1) can impede the functions of other
PHDs, we characterized the histone-binding activity of the
JARID1A PHD3 finger. Addition of (1) to the 15N-labeled
JARID1A PHD3 finger, prebound to the unlabeled H3K4me3
peptide, led to substantial CSPs and nearly restored the spec-
trum of the ligand-free PHD finger at a protein:H3K4me3:(1)
ratio of 1:5:10 (Fig. 6). Much like the reverse pattern of CSPs
observed earlier for ING2, the reverse pattern of CSPs for
JARID1A indicated dissociation of the JARID1A PHD3-
FIGURE 6. Calixarenes exhibit selectivity for the PHD fingers of JARID1A and MLL1. a, the crystal structure of the JARID1A PHD3 finger in complex with
H3K4me3 peptide (PDB code 3GL6). The aromatic cage residues are colored yellow. b, superimposed 1H,15N HSQC spectra of JARID1A PHD3, collected as first
H3K4me3 peptide and then (1), (4), or (7) were titrated in. The spectra are color-coded according to the protein:peptide:calixarene molar ratio. c, overlays of
1H,15N HSQC spectra of the H3K4me2-bound JARID1A PHD3 recorded during titration with (1). d, superimposed 1H,15N HSQC spectra of MLL1 PHD3 collected
as first H3K4me3 peptide and then (1), (4), and (7) were added gradually. e, the crystal structure of the MLL1 PHD3 finger in complex with H3K4me3 peptide
(PDB code 3GL6). The aromatic cage residues are colored blue. f, the normalized chemical shift changes observed in the MLL1 PHD finger upon binding to
H3K3me3 (red) and inhibition by (1) or (4) (blue) as a function of residue.
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H3K4me3 complex. Although the JARID1A PHD3 finger has a
more shallow aromatic cage, it binds to H3K4me3 twice as
strong as ING2 PHD binds to H3K4me3 (3, 11). Accordingly, at
least twice more of (1) was required to inhibit the association of
the JARID1A PHD3 finger with H3K4me3. As expected, nei-
ther (4) nor (7) were able to perturb the JARID1A PHD3-
H3K4me3 complex. Together, the NMR titration experiments
suggest that the PHD-H3K4me3 complex dissociation con-
stants, rather than the aromatic cage geometry, drive inhibition
by calixarenes.
Unlike the ING2 PHD finger that binds to H3K4me2 10-
fold more weakly than it binds to H3K4me3, the JARID1A
PHD3 finger recognizes both methylated states equally well (Kd
values of 0.8 and 0.9 M for H3K4me2 and H3K4me3, respec-
tively) (3, 11). Titration of (1) into the JARID1A PHD3-
H3K4me2 complex resulted in no CSPs, indicating that (1) is
incapable of eliminating binding of the JARID1A PHD3 finger
to H3K4me2 (Fig. 6c).
Calixarenes Disrupt Weak Complexes of MLL1 and MLL5—
Whereas ING2 and JARID1A PHDs represent typical PHD
modules, with binding affinities toward H3K4me3 being in the
range of 1–10 M, the PHD fingers of MLL1 and MLL5 bind
H3K4me3 much weaker (Kd values of  20 M) and associate
with H3K4me2 in the 100 –200 M range (3, 11, 36 –38).
Despite the fact that trimethylated lysine in the MLL1
PHD3-H3K4me3 complex is completely buried in the aro-
matic cage, all tested calixarenes, including (1), (4), and (7),
were able to inhibit this interaction on the basis of reverse
CSPs observed in the HSQC titration experiments (Fig. 6d).
Furthermore, (1) and (4) abolished the interaction equally
well (Fig. 6f), implying that a particular calixarene host could
be chosen to eliminate the histone binding activity of a par-
ticular PHD finger. For instance, (4) disrupts the complex of
the MLL1 PHD finger, whereas it does not disrupt the com-
plexes of ING2 or JARID1A PHD fingers at the same calix-
arene concentration.
FIGURE 7. Calixarenes block the histone-binding activity of the MLL5 PHD finger in vitro and in vivo. a, crystal structure of the MLL5 PHD finger in complex
with H3K4me3 peptide (PDB code 2LV9). The aromatic cage residues are colored green. b, superimposed 1H,15N HSQC spectra of MLL5 PHD, collected as first
H3K4me3 peptide and then (1), (4), or (7) were titrated in. The spectra are color-coded according to the protein:peptide:calixarene molar ratio. c, quantitation
of the interaction of MLL5 PHD with H3 (black) or H3K4me3 (blue) peptides by fluorescence polarization (left) or fluorescence polarization displacement (right)
by (1). d, overlays of 1H,15N HSQC spectra of the H3K4me2-bound MLL5 PHD recorded during titration with (1) or (7). e, binding of the GST-fusion MLL5 PHD
finger to the indicated biotinylated histone peptides in the absence or presence of the indicated calixarenes.
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We next examined whether calixarenes can impede binding
of the MLL5 PHD finger that contains a single aromatic residue
in the binding cage using NMR and pulldown assays (Fig. 7). We
found that (1), (4), (7), and (8) impair binding of the MLL5 PHD
finger to H3K4me3, although (7) does so weakly (Fig. 7b). Inhi-
bition by (1) was dose-dependent and had an IC50 of 37 M as
measured by fluorescence polarization (Fig. 7c). Moreover, (1)
and (7) were capable of disrupting a weak (Kd, 104 M) complex
of the MLL5 PHD finger with H3K4me2 (Fig. 7, d and e). These
findings reinforce our conclusion that the topology of the aro-
matic cage appears to have no effect on the inhibition but bind-
ing affinity does play a significant role. These results also sug-
gest that calixarenes (4), (7), and (8) can be used to block the
H3K4me-binding activity of the PHD fingers that weakly inter-
FIGURE 8. Calixarene (1) disrupts binding of MLL5 to H3K4me3 in vivo. a, C2C12 cells expressing FLAG-MLL5 were fixed and stained with anti-FLAG
and anti-H3K4me3 antibodies and with secondary antibodies conjugated with Duolink PLA probes and Duolink PLA detection reagents and imaged
using a fluorescence microscope. Yellow dots specify interacting foci. Nuclei are labeled blue (DAPI). b, mean  S.E. of MLL5-H3K4me3-interacting foci
per indicated cells. c, percentage of cells with 5–9 (blue) and more than 10 (red) MLL5-H3K4me3-interacting foci. The remaining cells (not shown) contain
0 – 4 foci. d, levels of FLAG-MLL5 were evaluated by Western blot analysis upon doxycycline (DOX) induction for 24 h. PARP-1 was used as a loading
control. e, levels of FLAG-MLL5 were evaluated by immunofluorescence microscopy upon doxycycline induction for 24 h. Identical exposure settings
and histogram adjustments were used for each condition (uninduced, left panel, and induced, right panel). f, H3K4me3 levels in C2C12:FLAG-MLL5 cells.
Cells were treated with or without 100 M (1) and processed for immunofluorescence. A z-slice from the nuclear midpoint is shown. Identical exposure
settings and histogram adjustments were used for each condition.
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act with this PTM (Kd, 	20 M) while not affecting the strong
PHD-H3K4me complexes (Kd, 1 M).
Displacement of MLL5 by (1) in Vivo—Recruitment of MLL5
to chromatin has been shown to rely on binding of its PHD
finger to H3K4me3 (36). To determine whether calixarene
inhibitors can disrupt the interaction of the PHD finger with
H3K4me3 in vivo, we tested the chromatin localization of
MLL5 using a Duolink PLA (Fig. 8). We have previously opti-
mized this assay to detect specifically and only directly interact-
ing MLL5-H3K4me3 foci (36). We generated a C2C12 cell line
with an inducible full-length murine MLL5 harboring an N-ter-
minal FLAG tag. C2C12:FLAG-MLL5 cells were treated with
100 M (1) and subjected to the PLA with primary antibodies
against the FLAG tag and H3K4me3. FLAG-MLL5-H3K4me3-
interacting foci were detected by microscopy as fluorescent
spots. In agreement with a previous report (36), in the absence
of inhibitors, a large number of fluorescent spots were observed
in each nucleus, indicating that MLL5 localizes at the genomic
regions enriched in H3K4me3 (Fig. 8a, center panel). However,
treatment of the cells with (1) substantially decreased the num-
ber of interacting foci, suggesting that MLL5 is disengaged from
chromatin when calixarene is present (Fig. 8a, right panel).
Quantitative analysis of the experiments confirmed that treat-
ment with (1) considerably reduced both the mean number of
spots per cell and the fraction of cells with multiple spots (Fig. 8,
b and c). These results are consistent with in vitro inhibition
data and demonstrate that (1) can be used to eliminate the
MLL5 PHD-H3K4me3 interaction in intact cells.
Concluding Remarks—Impaired histone-binding function of
PHD fingers causes mislocalization and nuclear-to-cytosolic
redistribution of the host proteins and chromatin-associating
complexes, leading to genomic instability and deregulation of
various signaling pathways (39). Developing novel approaches
to manipulate the activities of these proteins and complexes can
be pivotal for understanding alterations in chromatin structure
and gene expression patterns. A well documented link between
aberrant activities of PHD finger-containing proteins and vari-
ous human diseases points to vast therapeutic potential. There-
fore, designing inhibitors of the PHD-histone interactions is
also essential for advancing cutting edge, epigenetically driven
therapeutic strategies (21).
In this study, we show that supramolecular caging com-
pounds impair the association of the PHD fingers with meth-
ylated H3K4 tails. The inhibitory activity of calixarenes
depends on differences in binding affinities and the methyla-
tion state of the histone ligand and can be augmented toward
certain PHD finger-histone complexes by further amending the
caging compound. We demonstrate that calixarenes can target
trimethyllysine and disrupt PHD-H3K4me3 complexes in vitro
and in vivo. A unique architecture of the H3K4me3-PHD inter-
face, the geometric complementarity of calix[4]arenes to the
trimethyllysine-binding aromatic cage, and their cell permea-
bility substantially widen the experimental applicability of the
supramolecular hosts (40). We expect these compounds to be
used as novel tools in a wide array of biochemical assays, histone
peptide microarrays, and high-throughput screens that aim to
identify novel methyllysine readers and characterize histone bind-
ing mechanisms of known epigenetic readers. We note that fur-
ther studies are necessary to examine whether calixarenes can dis-
rupt complexes of other readers of the H3K4me3 PTM, including
CHD1 double chromodomains, tandem Tudor domains of
JMJD2A and SGF29, and a CW zinc finger of ZCWPW1 (41–44).
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H. F. A., and J. L. performed experiments and, together with B. D. S.,
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with input from all authors.
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